Web-based questionnaire study to investigate patients' and physicians' perspectives regarding factors affecting patients' satisfaction and adherence to treatment, continuation/discontinuation of treatment, and clinical inertia in type 2 diabetes management

JRCT ID: jRCT1080224567

Registered date:19/02/2019

Basic Information

• Recruitment status: completed
• Health condition(s) or Problem(s) studied: Type 2 diabetes
• Date of first enrollment: 06/03/2019
• Target sample size: 1726
• Countries of recruitment: Japan
• Study type: Observational

Intervention(s)

investigational material(s)
Generic name etc : Not Applicable due to Web-based questionnaire study
INN of investigational material : -
Therapeutic category code : 396 Antidiabetic agents
Dosage and Administration for Investigational material : -

control material(s)
Generic name etc : -
INN of investigational material : -
Therapeutic category code :
Dosage and Administration for Investigational material : -

Outcome(s)

Primary Outcome

other
[Survey in physician]
Characteristics (Including screening item): 7 questions
[Survey in patient]
Characteristics (Including screening item): 20 questions

Timeframe: 12 days
other
[Survey in physician]
Measurement item: 24 questions
[Survey in patient]
Measurement item: 27 questions

Timeframe: 12 days

Secondary Outcome

other
-

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

[Physician survey]
1.Medical experience in type 2 diabetes more than 3 years.
2.Treat more than 50 patients with type 2 diabetes per month

[Patient survey]
1.20 years old or older
2.Have type 2 diabetes
3.Not a healthcare provider

• Exclude criteria: -

Related Information

• Primary Sponsor: Takeda Pharmaceutical Company Limited
• Secondary Sponsor: -
• Source(s) of Monetary Support: -
• Secondary ID(s): JapicCTI-194636